In The Gambia, a visit to the clinic for HIV services is no longer just one step in a long process: clients now experience ...
Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the ...
Gambia's story with HIV treatment is witnessing a monumental shift.A visit to the clinic for HIV services is no longer just one step in a long process: clients now experience bespoke, integrated ...
Around 30% of people in The Gambia who test HIV-positive do not start treatment immediately, often because services are too ...
The Rwanda Biomedical Centre (RBC) is finalising preparations for the rollout of lenacapavir, a long-acting injectable drug for HIV prevention, expected to be introduced in November.The preparations ...
In the latest close session, Gilead Sciences (GILD) was down 3.72% at $129.83. The stock's performance was behind the S&P 500 ...
Eight months after the Supreme Court of Appeal gave the green light for specially trained pharmacists to dispense antiretrovirals without a script from a doctor, the programme remains stuck in the ...
Objective The aim of the study was to assess the psychometric properties of the Afaan Oromoo version of Generalised Anxiety ...
Ahead of a major surgery, one of Dr Gargi’s relatives who was battling cancer needed a blood transfusion. Despite being ...
Gilead Sciences stock has delivered a strong 5 year run, yet current valuation checks paint a more mixed picture. The overall ...
Over the past several decades, TB control programmes have made significant progress in expanding diagnosis and treatment ...